The first established therapy for hepatitis C was interferon (IFN) reported by Hoofnagle et al. in 1986, wherein administration of human recombinant IFN-α resulted in normalization of transaminases in patients with non-A, non-B hepatitis [5]. The gene discussed is IFNA1; the disease is Hepatitis.